Launch of BioLabs | TUM

BioLabs is a network of shared laboratory facilities located in key geographies within well-established as well as more nascent biotech innovation clusters in the US, Japan, France and Germany. BioLabs offers a unique environment of coworking spaces that pair fully equipped and supported laboratories with furnished office space, and active community-building. BioLabs provides entrepreneurs with unparalleled access to capital through its affiliated venture fund Mission BioCapital and numerous industry partnerships. These fertile, supportive ecosystems allow young companies to shift their focus from lab buildout and operations to experimentation and innovation so that they can quickly reach their scientific potential and achieve business success. The BioLabs network of coworking lab facilities now comprises 17 sites, with additional sites under development. Munich will be the third lab location for BioLabs in Germany after Heidelberg and Berlin. 

www.Biolabs.io

Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. 

www.lilly.com/de

• Start-ups, researchers and teams of all backgrounds are welcome — including TUM spin-offs, external founders, and student teams. 
   
• BioLabs has supported over 1,200 start-ups, from early-stage student projects to experienced biotech ventures. What matters is your potential, not your origin.

• Applications are accepted on a rolling basis via https://www.biolabs.io/munich
   
• After a pre-screening, selected startups pitch at a monthly Selection Committee meeting.

• There’s no strict stage requirement.
• Most resident start-ups are in the preclinical to early clinical phase (up to Phase I/II). You can stay as long as the lab infrastructure supports your development needs.

• Start-ups and teams pay rent based on their space usage (e.g., number of lab benches or desks).

• High-end infrastructure — no build-up needed
  State-of-the-art laboratories and office space right in central Munich let you focus on science and scaling.
   
• Direct access to pharma, academic, and investor networks
  Benefit from curated mentoring and strategic input from global pharma leaders, top researchers, and leading VCs.
   
• Global exposure with local roots
  Through BioLabs' international network and Lilly’s venture reach, your start-up is visible to the right partners — while staying connected to Munich’s ecosystem.
   
• Deep integration with TUM Venture Labs & our ecosystem
  Our teams can actively recommend promising start-ups, help prepare strong applications, and maintain close ties for continued coaching, visibility, and funding connections.
   
• Stronger retention & accelerated growth
  Having premium lab space in Munich enables start-ups to stay longer in the ecosystem — strengthening collaboration, mentorship, and long-term impact.